Exchange: NYSE
Industry: Health Care Equipment & Services
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
28,771,000 | 27,302,000 | 27,266,000 | 27,285,000 | 25,918,000 |
Premiums Earned |
25,848,000 | 24,640,000 | 24,609,000 | 24,631,000 | 23,361,000 |
Total Investment Income |
138,000 | 125,000 | 128,000 | 133,000 | 135,000 |
Realized Gains (Losses) |
49,000 | 20,000 | 51,000 | 42,000 | 9,000 |
Other Operating Income |
2,736,000 | 2,517,000 | 2,478,000 | 2,479,000 | 2,413,000 |
Losses, Claims & Reserves |
20,803,000 | 19,471,000 | 20,013,000 | 19,939,000 | 18,621,000 |
Losses, Benefits & Adjustments |
20,803,000 | 19,471,000 | 20,013,000 | 19,939,000 | 18,621,000 |
Long Term Insurance Reserves |
0 | NA | NA | NA | NA |
Selling, General & Admin. Expenses & Other |
5,865,000 | 5,221,000 | 5,026,000 | 5,026,000 | 5,221,000 |
Selling, General & Admin. Expenses |
5,223,000 | 4,594,000 | 4,406,000 | 4,392,000 | 4,308,000 |
Other Selling, General & Admin. Expense |
5,223,000 | 4,594,000 | 4,406,000 | 4,392,000 | 4,308,000 |
Other Operating Expense |
642,000 | 627,000 | 620,000 | 634,000 | 913,000 |
Operating Income Before Interest Expense |
2,103,000 | 2,610,000 | 2,227,000 | 2,320,000 | 2,076,000 |
Interest Expense, Net of Interest Capitalized |
173,000 | 158,000 | 153,000 | 148,000 | 139,000 |
Interest Expense (excl. Interest Capitalized) |
173,000 | 158,000 | 153,000 | 148,000 | 139,000 |
Operating Income After Interest Expense |
1,930,000 | 2,452,000 | 2,074,000 | 2,172,000 | 1,937,000 |
Miscellaneous Non Operating Expense |
0 | 0 | 0 | 0 | 0 |
Equity in Affiliates (Pretax) |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
2,000 | 0 | 1,000 | 3,000 | 2,000 |
Pretax Income |
1,928,000 | 2,452,000 | 2,073,000 | 2,169,000 | 1,935,000 |
Income Taxes |
684,000 | 895,000 | 736,000 | 781,000 | 677,000 |
Equity in Affiliates |
0 | 0 | NA | NA | 0 |
Consolidated Net Income |
1,244,000 | 1,557,000 | 1,337,000 | 1,388,000 | 1,258,000 |
Minority Interest Expense |
0 | 0 | 0 | 0 | 0 |
Net Income |
1,244,000 | 1,557,000 | 1,337,000 | 1,388,000 | 1,258,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | NA | NA | 0 |
Net Income After Extraordinaries |
1,244,000 | 1,556,999 | 1,336,999 | 1,388,000 | 1,258,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Inc. Avail. To Common - Basic |
1,244,000 | 1,557,000 | 1,337,000 | 1,388,000 | 1,258,000 |
Operational EPS |
1.19 | 1.50 | 1.28 | 1.31 | 1.16 |
EPS (basic) |
1.22 | 1.52 | 1.30 | 1.34 | 1.18 |
Common Shares Outstanding |
1,046,000 | 1,039,000 | 1,049,000 | 1,060,000 | 1,087,000 |
Basic Shares Outstanding |
1,027,000 | 1,022,000 | 1,028,000 | 1,039,000 | 1,070,000 |
Diluted Shares Outstanding |
1,046,000 | 1,039,000 | 1,049,000 | 1,060,000 | 1,087,000 |
Diluted EPS after Extraordinary Items |
1.19 | 1.50 | 1.27 | 1.31 | 1.16 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
1.21 | 1.52 | 1.30 | 1.34 | 1.16 |
*Figures in thousands of U.S. Dollars except shares outstanding.
